Michele Kearney's Nuclear Wire

Major Energy and Environmental News and Commentary affecting the Nuclear Industry.
Showing posts with label Cadarache. Show all posts
Showing posts with label Cadarache. Show all posts

Tuesday, October 12, 2010

Facilitating Fusion Research

Facilitating Fusion Research

IAEA has always played an important role in facilitating safe and environmentally responsible nuclear energy sources.
Commercial fusion reactors are yet a theoretical possiblity. To help overcome the challenges presented in demonstrating the technological and commercial feasibility of generating electricity using fusion power, the IAEA has been collaborating with the international fusion community, and in particular with researchers at the ITER organization. ITER's partners and experts are building the world’s first international demonstration reactor for fusion power in Cadarache, France. 
Enhanced by Zemanta

Tuesday, September 21, 2010

European Union Reactor Operators Sign Nuclear Research Policy

The French Alternative Energies and Atomic Energy Commission (CEA), Belgian Nuclear Research Centre SCK•CEN and Nuclear Research & Consultancy Group (NRG) have partnered to establish the European Research Area of Experimental Reactors (ERAER) which stresses the importance of cooperation and implementation of a clear policy roadmap for activities in European research reactors.
The policy includes a mid- and long-term roadmap for the new European research reactors. CEA (France), SCK•CEN (Belgium) and NRG (the Netherlands) allocated the following main functions for their new reactors:
  • Reactor Jules Horowitz (Cadarache, France): a high performance materials testing reactor, already under construction;
  • MYRRHA (Mol, Belgium): a flexible fast spectrum irradiation research facility; and
  • Pallas (Petten, the Netherlands): a research reactor as the main European producer for medical isotopes.
The ERAER paper was signed during the General Assembly of the Sustainable Nuclear Energy Platform in Brussels. It emphasizes the following necessary irradiation infrastructure in the future nuclear research area:
  • Opportunities for materials and fuel testing to support reactor safety, plant life management, optimization and innovation for current and future nuclear power reactors;
  • Development of a flexible fast spectrum irradiation facility in order to put Europe in a leading position in the worldwide search for sustainable nuclear energy for tomorrow; and
  • Radioisotope production for nuclear medicine, a major commitment to public health.
Enhanced by Zemanta